BMS Resources · Clinician Reference Series
Integrative assessment and treatment of HPA-axis dysregulation, burnout, and stress-related fatigue, mood and sleep disturbance.
For licensed practitioners — supportive clinical reference, not medical advice.Chronic stress presentations sit at the intersection of impaired glucocorticoid negative feedback, autonomic imbalance, circadian disruption, and allostatic load. Cortisol normally suppresses CRH and ACTH through the glucocorticoid receptor; sustained stress blunts this brake, and the resulting loss of diurnal rhythm — rather than any absolute cortisol value — is what drives the clinical picture. The amygdala simultaneously activates the hypothalamus (CRH) and the locus coeruleus (sympathetic outflow), so the HPA axis and the autonomic nervous system function as one stress system: catecholamines potentiate ACTH and cortisol, and cortisol in turn raises resting sympathetic tone, lowers HRV, and impairs the baroreflex. The loop reinforces itself.
Downstream, dysregulation reaches cardiometabolic health (insulin resistance, visceral fat, hypertension, dyslipidemia), immunity (glucocorticoid resistance driving chronic low-grade inflammation), mood and cognition (hippocampal and prefrontal impact), the gut-brain axis, and cellular aging (telomere attrition, senescence). This is why the stress conversation belongs in a metabolic, oncologic or longevity consult — not only a mental-health one.
"Adrenal fatigue" is a misnomer. Frame it as HPA-axis dysfunction, not gland failure. The glands are rarely the problem; the regulation is. That distinction determines everything downstream — including whether the patient needs axis support or a referral for glucocorticoid replacement.
Common upstream contributors to screen for at intake: exogenous glucocorticoids (inhaled, topical, oral — patients routinely don't count these), shift work, early-life adversity, untreated sleep apnea, thyroid dysfunction, caregiving or financial load, and overtraining.
Sequence matters — layering adaptogens onto a patient still sleeping five hours in a lit bedroom buys very little, and it teaches the patient that supplements didn't work.
Each lever in this protocol targets a specific node:
Four parts, worked in order: history & questionnaires, physical exam, targeted labs, careful interpretation. Labs answer questions the history has already raised — not the reverse.
Key history elements: stressor timeline and perceived control · sleep, energy and diurnal pattern · caffeine, alcohol and substances · work, caregiving and financial load · trauma and early-life adversity · exogenous steroids (inhaled/topical/oral) · menstrual, thyroid and metabolic history.
Ask how long it takes the patient to feel normal again after a period of pressure. A patient who needs a month or more to recover from a stretch of high demand is telling you something about recovery capacity that no single lab value will.
| Instrument | Measures | Scoring |
|---|---|---|
| PSS — Perceived Stress ScaleGlobal stress appraisal; trackable over time | Perceived stress | 0–40 |
| PHQ-9Review item 9 (suicidal ideation) at every administration | Depression | 5 mild · 10 moderate · 15 mod-severe · 20 severe |
| GAD-7 | Anxiety | 5 mild · 10 moderate · 15 severe |
| MBI — Maslach Burnout InventoryExhaustion, cynicism, professional efficacy | Occupational burnout | Subscale-based |
| PSQI — Pittsburgh Sleep Quality Index | Sleep quality | >5 = poor sleep |
| ACE — Adverse Childhood ExperiencesCumulative-risk screen; introduce with care and context | Early-life adversity | 0–10 |
Baseline exam: BP with orthostatics · BMI and waist circumference · thyroid · skin and hair · resting HR and HRV where available. Overt Cushing's or Addison's is rare — most patients show subtle, functional shifts.
Serum for gland or axis pathology · saliva for free-cortisol rhythm · urine for total output and metabolism. Ordering all three is not thoroughness, it's noise.
| Test | Specimen | When to use it |
|---|---|---|
| Paired AM & PM cortisolStandard requisition | Serum | First-line when true pathology is on the differential; establishes the diurnal drop. |
| ACTH & DHEA-S | Serum | Localizes the level of the lesion; DHEA-S indexes adrenal reserve. |
| Dexamethasone suppression / ACTH stimulationOrder or refer according to scope and provincial rules | Serum | When Cushing's or Addison's is genuinely suspected — refer rather than manage. |
| TSH, fasting glucose & insulin, ferritin, CBC | Serum | Confounder screen — never interpret a cortisol curve without these. |
| 4-point diurnal curve & CARRecord wake time and shift-work pattern alongside the sample | Saliva | The workhorse for functional rhythm assessment. |
| Late-night salivary cortisol | Saliva | Screening for hypercortisolism; also flags circadian disruption. |
| Salivary DHEA & cortisol:DHEA ratio | Saliva | Catabolic vs anabolic balance; a low ratio suggests reduced reserve. |
| 24-hour urinary free cortisol | Urine | Total output; markedly elevated results warrant endocrinology referral. |
| Dried urine metabolites (e.g. DUTCH)Exploratory — frame the uncertainty for the patient before ordering | Urine | When free cortisol looks normal but the picture doesn't; maps production and clearance. |
Free cortisol tells you rhythm; metabolites tell you total output; ratios tell you how the body handles it.
| Pattern | What it suggests | Where to aim treatment |
|---|---|---|
| Flattened curveLoss of the AM–PM slope | Chronic stress, burnout, poor sleep; associated with worse outcomes across multiple endpoints. | Circadian reset first; foundations before botanicals. |
| Elevated CAR / high AM | Anticipatory stress, early dysregulation. | Correlate with sleep and mood before acting; mind-body work is high-yield here. |
| Low overall output | Blunted response, advanced dysregulation. | Rule out true adrenal insufficiency before calling it functional. |
| High evening cortisol | Circadian disruption; the classic "wired but tired" patient. | Light exposure, sleep hygiene, evening-dosed calming support. |
Build the base before layering targeted therapies. Adaptogens added to a five-hour sleeper deliver little, and the patient concludes supplements don't work.
Low HRV is a measurable marker of combined ANS–HPA dysregulation. Slow breathing and HRV biofeedback restore vagal tone and dampen the axis — a physiologic intervention, not an adjunct.
| Resource | Category | Direct link |
|---|---|---|
| Palouse MindfulnessComplete free online MBSR course — the strongest no-cost referral on this list | Free | Open resource |
| Insight TimerLarge free guided meditation library | Free | Open resource |
| UCLA MindfulFree guided practices from UCLA Health | Free | Open resource |
| VA Mindfulness CoachStructured, trauma-informed, entirely free | Free | Open resource |
| HeartMathHRV biofeedback hardware and training | Breathing & HRV | Open resource |
| Calm · Headspace · Ten Percent HappierSubscription meditation apps | Low-cost / freemium | — |
| Breathwrk · Othership · consumer HRV trackers | Breathing & HRV | — |
| Local MBSR courses, yoga studios, peer support, workplace EAPCheck whether the patient's employer already funds counselling sessions | Community | — |
Adaptogens buffer the stress response and help normalize the axis rather than forcing it in one direction. Verify standardization, quality and interactions before recommending.
| Botanical | Clinical role | Cautions |
|---|---|---|
| AshwagandhaWithania somnifera | Lowers cortisol and perceived stress; aids sleep. Dual role in stress-related insomnia. | Thyroid disease, pregnancy, nightshade allergy. |
| RhodiolaRhodiola rosea | Anti-fatigue, focus under stress. Morning dosing. | Bipolar disorder, agitation; avoid PM dosing. |
| Holy basilOcimum sanctum (Tulsi) | Calming with glycemic support. | May affect clotting and fertility. |
| Asian ginsengPanax ginseng | Energy and resilience in the low-output phenotype. | Hypertension, stimulants, insomnia. |
| EleutheroEleutherococcus senticosus | Endurance and stress tolerance. | Hypertension. |
| SchisandraSchisandra chinensis | Adaptogenic, hepatoprotective, focus support. | Generally well tolerated; review CYP-mediated interactions. |
Elevated evening cortisol, "wired but tired", trouble switching off at night. Dose these in the evening — morning dosing wastes the mechanism.
Blunted response and low overall output. Rule out true adrenal insufficiency before treating this as functional — see the referral ladder.
Appropriate for mild-to-moderate presentations (PHQ-9 / GAD-7 under 15) alongside lifestyle and mind-body work. At moderate-severe or above, refer — see the referral ladder.
Sleep is both driver and consequence here. Pair any product below with circadian and sleep-hygiene work — supplements alone rarely fix a flattened curve.
The most important distinction on this page: supporting a dysregulated-but-intact axis is not the same as replacing a failing gland.
| Consideration | Glandulars — integrative | Hydrocortisone — referred care |
|---|---|---|
| What it is | Adrenal cortex or whole-adrenal (± hypothalamic-pituitary) extracts. | Physiologic glucocorticoid replacement. |
| Rationale / indication | Supplies adrenal cofactors and peptides to support a dysregulated-but-intact axis; used for fatigue and low-reserve patterns. | Cornerstone therapy for confirmed adrenal insufficiency (Addison's, secondary AI) — endocrinology-managed. |
| Evidence | Largely traditional and anecdotal; few controlled trials. | Established for diagnosed AI. Low-dose HC (the "Jefferies protocol") for non-Addisonian fatigue is not standard of care. |
| Cautions | Variable potency; possible residual corticosteroids or hormones that themselves suppress the axis; sourcing and contamination risk. Avoid in pregnancy; use care in autoimmunity. | Risks HPA suppression and iatrogenic Cushing's. Any exogenous cortisol suppresses the axis. |
| Refer when | Symptoms persist despite foundations plus 8–12 weeks of appropriate support. | Abnormal serum cortisol or ACTH, positive dexamethasone suppression or ACTH-stimulation testing, or signs of true adrenal insufficiency. |
Hormone-containing glandulars and exogenous cortisol both suppress the HPA axis. Use either only with a clear indication, documented informed consent, reputable sourcing, and appropriate oversight.
A severity ladder. Establish where the patient sits on it before you build the plan.
Disclaimer. This protocol is provided for educational purposes for licensed healthcare practitioners. It is not a substitute for clinical judgment, full patient assessment, or current local standards of care. BMS Resources does not provide medical advice. Practitioners are responsible for verifying that recommended products, doses, and tests are appropriate for their patient and jurisdiction. Dose ranges reflect typical practitioner-level adult dosing; individualize for the patient's clinical picture, comorbidities, and concurrent pharmacotherapy. Adapted from Beyond Burnout: An Integrative Approach to Stress, Cortisol & the HPA Axis — Dr. Eric Marsden, ND.
